EP 4125929 A1 20230208 - NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
Title (en)
NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
Title (de)
NICOTINAMID-MONONUKLEOTID-DERIVATE ZUR BEHANDLUNG VON BAKTERIELLEN INFEKTIONEN
Title (fr)
DÉRIVÉS DE NICOTINAMIDE MONONUCLÉOTIDES POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES
Publication
Application
Priority
- FR 2003085 A 20200327
- EP 2021057938 W 20210326
Abstract (en)
[origin: WO2021191422A1] The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof; (I), in which X, R1, R2, R3, R4, R5, R6, R7, R8, Y, line (II) and line (III) are as described in the claims, for the use thereof in the treatment of bacterial infections.
IPC 8 full level
A61K 31/706 (2006.01); A61K 9/00 (2006.01); A61K 31/7084 (2006.01); A61K 45/06 (2006.01); A61P 31/04 (2006.01); A61P 31/06 (2006.01)
CPC (source: EP US)
A61K 31/706 (2013.01 - EP US); A61K 31/7084 (2013.01 - EP US); A61K 45/06 (2013.01 - EP); A61P 31/04 (2018.01 - EP US); A61P 31/06 (2018.01 - EP); Y02A 50/30 (2018.01 - EP)
Citation (examination)
- WO 2016149395 A1 20160922 - CHROMADEX INC [US], et al
- US 2017296564 A1 20171019 - DELLINGER RYAN [US], et al
- See also references of WO 2021191422A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021191422 A1 20210930; AU 2021245030 A1 20221103; CA 3171744 A1 20210930; CN 115697349 A 20230203; EP 4125929 A1 20230208; FR 3108502 A1 20211001; FR 3108502 B1 20220923; JP 2023526726 A 20230623; US 2023210881 A1 20230706
DOCDB simple family (application)
EP 2021057938 W 20210326; AU 2021245030 A 20210326; CA 3171744 A 20210326; CN 202180033681 A 20210326; EP 21713440 A 20210326; FR 2003085 A 20200327; JP 2022558101 A 20210326; US 202117914576 A 20210326